Intellia Therapeutics financial statements

인텔리아 테라퓨틱스NASDAQ:NTLA · Nasdaq · Healthcare · sector #17
$12.37-2.98%
2026-10-06 close

Intellia Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $58M. 2024 operating profit was −$534M.

Reported results

Intellia Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy